Nanovibronix (NASDAQ:FEED – Get Free Report) and Curaleaf (OTCMKTS:CURLF – Get Free Report) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.
Analyst Ratings
This is a summary of current recommendations for Nanovibronix and Curaleaf, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Nanovibronix | 1 | 0 | 0 | 0 | 1.00 |
| Curaleaf | 0 | 0 | 2 | 3 | 3.60 |
Risk and Volatility
Nanovibronix has a beta of 1.38, indicating that its share price is 38% more volatile than the S&P 500. Comparatively, Curaleaf has a beta of 1.57, indicating that its share price is 57% more volatile than the S&P 500.
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Nanovibronix | $1.93 million | 0.21 | -$18.18 million | ($117.28) | -0.00 |
| Curaleaf | $1.27 billion | 2.00 | -$231.07 million | ($0.13) | -83.54 |
Nanovibronix has higher earnings, but lower revenue than Curaleaf. Curaleaf is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Nanovibronix and Curaleaf’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Nanovibronix | -1,093.61% | -60.73% | -48.48% |
| Curaleaf | -2.62% | -0.88% | -0.26% |
Insider & Institutional Ownership
16.4% of Nanovibronix shares are owned by institutional investors. Comparatively, 0.0% of Curaleaf shares are owned by institutional investors. 12.2% of Nanovibronix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Curaleaf beats Nanovibronix on 10 of the 14 factors compared between the two stocks.
About Nanovibronix
NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.
About Curaleaf
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.
Receive News & Ratings for Nanovibronix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanovibronix and related companies with MarketBeat.com's FREE daily email newsletter.
